来自Cleome viscosa的烯酸乙酸作为心肌梗塞治疗候选药物
James Diokadan1, Ishimwe Aimée Divine1, Shamasamu Emma1
1Department of Pharmacology, College of Pharmacy, Koneru Lakshmaiah Education Foundation, KL Deemed to Be University, Green Fields, Vaddeswaram, Andhra Pradesh India.
In silico pharmacology
|July 7, 2025
概括
来自Cleome viscosa的卢佩酸盐显示出治疗心肌梗塞 (MI) 的前景. 计算分析确定JAK2是关键目标,支持其心脏保护潜力.
科学领域:
- 药理学和计算机生物学
- 自然产品 化学 化学
- 心血管研究研究心血管研究
背景情况:
- 烯酸,一个五环三烯酸,具有抗炎,抗氧化和心脏保护性质.
- 它是在Cleome viscosa叶的甲醇提取物中鉴定出来的.
- 乙烯露皮醇由于其有利的药理动力学和安全性,具有作为心肌梗塞 (MI) 的治疗剂的潜力.
研究的目的:
- 确定Cleome viscosa中的生物活性化合物,这些化合物对心脏病发作有潜在的治疗应用.
- 为了研究烯酸的心脏保护作用背后的分子机制.
- 评估已识别的化合物的药理动力学,药物相似性和毒性概况.
主要方法:
- 气色谱-质谱法 (GC-MS) 用于分析Cleome viscosa的甲醇提取物.
- 在 silico 工具 (SwissADME,MolSoft,ProTox-II) 中评估了药理动力学,药物相似性和毒性.
- 权重基因共同表达网络分析 (WGCNA) 和蛋白质与蛋白质相互作用 (PPI) 网络集成了omics数据以识别关键的枢纽基因,随后进行了分子动力学模拟.
主要成果:
- 在32种化合物中,烯酸被确定为具有有利的药理动力学,低毒性和高药物相似性的化合物.
- WGCNA确定了JAK2作为与MI,亡和炎症相关的关键枢纽基因.
- 分子对接和动力学模拟证实了烯酸和JAK2.2之间强大而稳定的结合.
结论:
- 烯酸是心肌梗塞的有希望的心脏保护候选人.
- 这项研究为Cleome viscosa对MI的影响的分子机制提供了新的见解.
- 建议进一步进行体内验证,以促进烯酸的治疗发展.
更多相关视频
09:05Minimal Invasive Surgical Procedure of Inducing Myocardial Infarction in Mice
Published on: May 4, 2015
28.0K
05:41Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control
Published on: December 16, 2022
3.7K
相关概念视频
01:19Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
49
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
49
01:30Acute Coronary Syndrome I: Introduction
80
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
80